Full Name
Thuan Tong Tan
Variants
Tan, T.T.
 
 
 
Email
gmstantt@nus.edu.sg
 

Publications

Results 1-12 of 12 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
12016A dedicated fungal culture medium is useful in the diagnosis of fungemia: A retrospective cross-sectional studyZheng S.; Ng T.Y. ; Li H. ; Tan A.L.; Tan T.T. ; Tan B.H.
22018A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated studyKalimuddin S. ; Chan Y.F.Z.; Phillips R.; Ong S.P.; Archuleta S. ; Lye D.C.; Tan T.T. ; Low J.G.H. 
321-Sep-2023COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore A Nationwide Cohort StudyTan, Wei Chong; Tan, Janice Yu Jin; Lim, Joline Si Jing ; Tan, Ryan Ying Cong ; Lee, Ainsley Ryan Yan Bin; Leong, Fun Loon; Lee, Soo Chin ; Chai, Louis Yi Ann ; Tan, Thuan Tong ; Malek, Muhammad Ismail Bin Abdul; Ong, Benjamin ; Lye, David Chien ; Chiew, Calvin J; Chng, Wee Joo ; Lim, Soon Thye ; Bharwani, Lavina D; Tan, Iain Beehuat; Sundar, Raghav ; Tan, Kelvin Bryan
42011Effective antibiotics in combination against extreme drug-resistant pseudomonas aeruginosa with decreased susceptibility to polymyxin BLim T.-P. ; Lee W.; Tan T.-Y.; Sasikala S.; Teo J.; Hsu L.-Y. ; Tan T.-T. ; Syahidah N.; Kwa A.L. 
52016From Bench-Top to Bedside: A prospective In vitro Antibiotic Combination Testing (iACT) service to guide the selection of rationally optimized antimicrobial combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)Cai Y.; Chua N.G.; Lim T.-P. ; Teo J.Q.-M.; Lee W.; Kurup A. ; Koh T.-H. ; Tan T.-T. ; Kwa A.L. 
62011In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against Carbapenem-resistant Acinetobacter baumannii in SingaporeLim T.-P. ; Tan T.-Y.; Lee W.; Sasikala S.; Tan T.-T. ; Hsu L.-Y. ; Kwa A.L. 
72017Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungsKale S.D. ; Dikshit N. ; Kumar P. ; Balamuralidhar V. ; Khameneh H.J.; Bin Abdul Malik N. ; Koh T.H. ; Tan G.G.Y.; Tan T.T. ; Mortellaro A.; Sukumaran B. 
82013Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: Study protocol for a randomized controlled trialMolton J. ; Phillips R. ; Gandhi M. ; Yoong J. ; Lye D. ; Tan T.T. ; Fisher D. ; Archuleta S. 
9Oct-2020Rapid production of clinical-grade SARS-CoV-2 specific T cells.Leung, Wing; Soh, Teck Guan; Linn, Yeh Ching ; Low, Jenny Guek-Hong ; Loh, Jiashen; Chan, Marieta; Chng, Wee Joo ; Koh, Liang Piu ; Poon, Michelle Li-Mei; Ng, King Pan ; Kuick, Chik Hong; Tan, Thuan Tong ; Tan, Lip Kun ; Seng, Michaela Su-Fern 
102012Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible enterobacteriaceae: A case-case-control studyTeo J.; Cai Y.; Tang S.; Lee W.; Tan T.Y.; Tan T.T. ; Kwa A.L.-H. 
112015Using an adenosine triphosphate bioluminescent assay to determine effective antibiotic combinations against carbapenem-resistant gram negative bacteria within 24 hoursCai Y.; Leck H.; Lim T.P. ; Teo J.; Lee W.; Hsu L.Y. ; Koh T.H. ; Tan T.T. ; Tan T.-Y.; Kwa A.L.-H. 
122014Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: Study protocol for a phase IIB randomized controlled trialKalimuddin, S ; Phillips, R; Gandhi, M ; de Souza, N.N ; Low, J.G.H ; Archuleta, S ; Lye, D ; Tan, T.T